The largest database of trusted experimental protocols

D12492

Manufactured by Merck Group
Sourced in United States

D12492 is a laboratory equipment product manufactured by Merck Group. It is a device designed to perform specific laboratory functions. The core function of this product is to assist in the processing and analysis of samples within a controlled laboratory environment.

Automatically generated - may contain errors

2 protocols using d12492

1

T2DM Induction Protocol with High-Fat Diet and STZ

Check if the same lab product or an alternative is used in the 5 most similar protocols
T2DM was induced using a combination of 2-week high-fat diet (Research Diet D12492 60 kcal% fat, USA), followed by a low dose (35 mg/kg) of streptozotocin (STZ, Sigma Chemical Co., St. Louis, MO) intraperitoneal injection and continued a high-fat diet for another 2 weeks (19 (link)). The fasting blood glucose was measured before STZ injection and 2 weeks after STZ injection by using a glucometer (Johnson & Johnson Co., New Brunswick, NJ, USA). The T2DM rat model was successfully established when the fasting blood glucose value of more than 16.7 mmol/L was measured at 2 weeks after STZ injection.
+ Open protocol
+ Expand
2

Obesity Induction and CD169+ ATM Depletion in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J, CCR2−/−, and CX3CR‐1GFP (B6.129P2(Cg)‐Cx3cr1tm1Litt/J) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6 CD169‐DTR mice were generated in our laboratory (Purnama et al, 2014 (link)) and crossed with CCR2−/− to obtain the final CCR2−/−CD169‐DTR mouse line. We used male mice only for these experiments. To induce obesity, mice aged 5–6 weeks were given a high‐fat diet (HFD) that comprised 60% kcal of fat (Research Diet, D12492, New Brunswick, NJ, USA) for 8, 12, or 16 weeks; age‐matched control mice were given a normal chow diet (ND).
CD169‐DTR+ and CD169‐DTR (WT) mice were intraperitoneally (i.p.) injected with 20 ng/g DT (Sigma) every 3–4 days to maintain the depletion of CD169+ ATMs. C57BL/6J mice were i.p. injected with rat IgG2a isotype control (BioLegend) or anti‐CSF1R blocking antibody (Clone AFS98, BioXCell, West Lebanon, NH, USA), twice per week (400 μg per mouse) for 12 days. No randomization nor blinding was used during our experiments.
All mice were bred and maintained in a specific‐pathogen‐free animal facility at Nanyang Technological University (NTU), Singapore. The mice experiments were carried out in strict accordance with the recommendations of the NACLAR (National Advisory Committee for Laboratory Animal Research) and approved by the Institutional Animal Care and Use Committee (IACUC) of NTU (ARF‐ SBS/NIE A18014).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!